Point72 (Difc) LTD Travere Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 21,315 shares of TVTX stock, worth $374,504. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,315Holding current value
$374,504% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
185Shares Held
89.6MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$134 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$132 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$129 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$116 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$78.8 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.13B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...